IRON DEFICIENCY ANEMIA IN CLINICAL PRACTICE

Authors

  • Muxtarov Saidorifxon Abduqodirxo'ja o'g'li Assistant of the Department of Faculty Therapy, Andijan State Medical Institute, Andijan, Uzbekistan Author

Keywords:

iron deficiency anemia, ferritin, transferrin saturation, hemoglobin, oral iron, intravenous iron, clinical practice.

Abstract

Iron deficiency anemia (IDA) is the most common nutritional and hematologic disorder encountered in clinical practice and remains an important cause of fatigue, impaired physical performance, cognitive dysfunction, reduced quality of life, and adverse maternal and pediatric outcomes. Despite the apparent simplicity of the diagnosis, clinically relevant errors continue to occur because hemoglobin alone does not define iron status, ferritin may be misleading in inflammatory states, and treatment without identification of the underlying cause can delay the diagnosis of gastrointestinal bleeding, gynecologic disease, malabsorption, or chronic inflammatory disorders. The aim of this review was to summarize contemporary principles for recognition, etiologic evaluation, treatment, and follow-up of IDA in routine clinical practice, while integrating evidence from international recommendations and recent studies from Uzbekistan. A focused narrative review of guidelines, expert reviews, randomized trials, and regional publications was performed. Current evidence supports a diagnostic strategy based on complete blood count indices, serum ferritin, transferrin saturation, and clinical assessment of inflammation. Oral ferrous preparations remain first-line therapy for many stable patients, whereas intravenous iron is appropriate when oral treatment is not tolerated, ineffective, poorly absorbed, or when rapid iron repletion is required. Modern dosing concepts favor once-daily or alternate-day oral administration rather than multiple daily doses in selected patients. The clinical objective is not only normalization of hemoglobin but also restoration of iron stores and correction of the source of iron loss. A structured, cause-oriented approach can improve therapeutic response, reduce recurrence, and prevent missed serious disease.

References

1.Abdiyev, K. M., Mamatkulova, F. X., & Gafarov, F. E. (2023). Trombotsitoz va anemiya bilan kechadigan temir tanqisligi anemiyasining kam uchraydigan holati [A rare case of iron deficiency anemia accompanied by thrombocytosis]. Problems of Biology and Medicine, 4(146), 210–215.

2.Camaschella, C. (2015). Iron-deficiency anemia. New England Journal of Medicine, 372(19), 1832–1843. https://doi.org/10.1056/NEJMra1401038

3.Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2020). Iron deficiency anaemia revisited. Journal of Internal Medicine, 287(2), 153–170. https://doi.org/10.1111/joim.13004

4.DeLoughery, T. G., Jackson, C. S., Ko, C. W., & Rockey, D. C. (2024). AGA Clinical Practice Update on management of iron deficiency anemia: Expert review. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.03.046

5.Iolascon, A., Andolfo, I., Russo, R., Sanchez, M., Busti, F., Swinkels, D., Aguilar Martinez, P., Bou-Fakhredin, R., Muckenthaler, M. U., Unal, S., Porto, G., Ganz, T., Kattamis, A., De Franceschi, L., Cappellini, M. D., Munro, M. G., & Taher, A. (2024). Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. HemaSphere, 8(7), e108. https://doi.org/10.1002/hem3.108

6.Pasricha, S.-R., Rogers, L., Branca, F., & Garcia-Casal, M.-N. (2024). Measuring haemoglobin concentration to define anaemia: WHO guidelines. The Lancet, 403(10440), 1963–1966. https://doi.org/10.1016/S0140-6736(24)00502-6

7.Pasupathy, E., Kandasamy, R., Thomas, K., et al. (2023). Alternate day versus daily oral iron for treatment of iron deficiency anemia: A randomized controlled trial. Scientific Reports, 13, 1818. https://doi.org/10.1038/s41598-023-29034-9

8.Ruzimatova, G. M. (2026). Reproduktiv yoshdagi temir tanqisligi kamqonligi bo‘lgan ayollarda og‘iz orqali va vena ichiga temir terapiyasini individual tanlash [Individualized selection of oral and intravenous iron therapy in women of reproductive age with iron deficiency anemia]. Zamonaviy tibbiyot jurnali, 14(3), 706–713. https://doi.org/10.67519/nshr.ztj.2026.03.100

9.Snook, J., Bhala, N., Beales, I. L. P., Cannings, D., Kightley, C., Logan, R. P. H., Pritchard, D. M., Sidhu, R., Surgenor, S., Thomas, W., Verma, A. M., & Goddard, A. F. (2021). British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut, 70(11), 2030–2051. https://doi.org/10.1136/gutjnl-2021-325210

10.Stoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: Two open-label, randomised controlled trials. The Lancet Haematology, 4(11), e524–e533. https://doi.org/10.1016/S2352-3026(17)30182-5

11.World Health Organization. (2024). Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. World Health Organization.

12.Zayniddinov, A. A. o‘g‘li, Ismoilova, S. Z., & Aʼzamova, F. A. qizi. (2026). Bolalarda temir tanqisligi anemiyasini erta aniqlashda laborator va klinik belgilarning diagnostik ahamiyati [Diagnostic significance of laboratory and clinical signs in the early detection of iron deficiency anemia in children]. Central Asian Journal of Academic Research, 4(5 Part 2), 62–64. https://doi.org/10.70413/cajar-v04-i05-p2-010

Downloads

Published

2026-08-28